MedPath

Mucosal Pressure of the Laryngeal Mask Airway Supreme Versus the i-Gel in Paralyzed Anesthetized Female Patients

Not Applicable
Completed
Conditions
Device Induced Injury
Necrosis, Pressure
Complication of Device Insertion
Airway Morbidity
Interventions
Device: Laryngeal Mask Airway Supreme
Device: i-Gel extraglottic airway device
Registration Number
NCT01367678
Lead Sponsor
Schulthess Klinik
Brief Summary

In the following randomized non-crossover study, the investigators test the hypothesis that directly measured mucosal pressure differ between the laryngeal mask airway (LMA) Supreme and the i-Gel in paralyzed anesthetized females.

Thirty females aged 19-65 years were randomly allocated to receive either the size 4 LMA Supreme or i-Gel for airway management. Microchip sensors were attached to the LMA Supreme/i-Gel at four locations corresponding to the A, base of tongue; B, distal oropharynx; C, hypopharynx; and D, pyriform fossa.

Insertion success rate and oropharyngeal leak pressure were also measured.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • ASA I/II
  • female
  • age 19-65 years
Exclusion Criteria
  • < 19 years
  • had a known or predicted difficult airway
  • a body mass index > 35 kg m-2, or
  • were at risk of aspiration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laryngeal Mask Airway SupremeLaryngeal Mask Airway SupremeDirectly measured mucosal pressures
i-Geli-Gel extraglottic airway deviceDirectly measured mucosal pressures
Primary Outcome Measures
NameTimeMethod
pharyngeal mucosal pressureevery 5 minutes during steady state anesthesia
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Christian Keller MD, M.Sc.

🇨🇭

Zürich, Switzerland

Medical University Innsbruck

🇦🇹

Innsbruck, Tyrol, Austria

© Copyright 2025. All Rights Reserved by MedPath